ASP Isotopes (ASPI) Stock News

ASP Isotopes (NASDAQ: ASPI) announced it will hold a Capital Markets Day in London on Tuesday, September 8, 2026, from 10:00 a.m. to 12:30 p.m. ET (3:00 p.m. to 5:30 p.m. BST). Leadership plans to present an update on strategic direction and commercial momentum, with detailed sessions on nuclear medicine, electronic gases, nuclear fuels, and related long-term market opportunities.

In-person attendance is invitation-only, but the public can join via a live webcast with prior registration, with materials and a replay available on the investor relations section of the company’s website. According to ASP Isotopes, the release also highlights a set of proposed merger and related transactions involving ENDRA Life Sciences, ASP Isotopes, Renergen, and Noble Africa, for which ENDRA plans to file a Form S-4 registration statement with the SEC containing a proxy statement and prospectus. Investors are urged to read these documents carefully when available, and the communication clarifies it does not constitute an offer or solicitation for any securities.

ASP Isotopes (NASDAQ: ASPI) announced that its wholly owned subsidiary Quantum Leap Energy (QLE) has signed a research agreement with the Texas A&M Engineering Experiment Station (TEES) to support commercialization of high-purity uranium hexafluoride (UF6), a key feedstock for nuclear fuel enrichment. The collaboration will collect fundamental physicochemical data on converting yellowcake uranium (U3O8) into UF6, with the aim of improving production efficiency, reducing costs, and enhancing scalability. According to the company, the work is expected to inform QLE’s process design, modeling, and scale-up activities, reinforce its uranium conversion technology efforts, and contribute to a more resilient U.S. nuclear fuel supply chain and a stronger nuclear ecosystem in Texas.

ASP Isotopes (NASDAQ:ASPI) and ENDRA Life Sciences (NASDAQ:NDRA) will participate in a RedChip investor webinar on July 21, 2026, at 4:15 p.m. ET, featuring Noble Africa, a wholly owned ASPI subsidiary and holding company for Renergen’s Virginia Gas Project.

The webinar will discuss Noble Africa’s proposed merger with ENDRA, which, if completed, is expected to result in Noble Africa becoming a Nasdaq-listed public company under the ticker “NOBA”. CEO Paul Mann will outline the Virginia Gas Project helium and LNG platform, its planned Phase 1 production ramp in 2026, Phase 2 expansion plans, key operational and financing milestones, and how a proposed Nasdaq listing is expected to support Noble Africa’s long-term growth strategy. A live Q&A session will follow.

ASP Isotopes (NASDAQ: ASPI) and its wholly owned subsidiary Quantum Leap Energy (QLE) entered into privately negotiated exchange agreements with certain holders of QLE’s convertible promissory notes. Holders agreed to exchange approximately $109.2 million in aggregate principal plus accrued interest for about 23.2 million ASPI common shares, representing roughly 17.8% of ASPI’s outstanding common stock.

The transactions are intended to cut QLE’s outstanding convertible notes by about 50%, reducing principal from $219.8 million to $110.7 million, simplify QLE’s capital structure as it pursues a separate U.S. listing, and support ASPI’s position for a potential future distribution of QLE equity. Closing is expected on July 16, 2026, subject to customary conditions.

ASP Isotopes (NASDAQ:ASPI) announced a Proposed Merger of its wholly owned subsidiary Noble Africa with a subsidiary of ENDRA Life Sciences (NASDAQ:NDRA). The surviving company plans to be renamed Noble Africa and apply to list on Nasdaq under the ticker NOBA.

In connection with the Proposed Transactions, Noble Africa has secured commitments for a concurrent private placement expected to generate approximately $50 million in gross proceeds, including about $20 million from ASP Isotopes and about $30 million from other investors, to support development of Renergen’s Virginia Gas Project.

ASP Isotopes (NASDAQ: ASPI)/b) announced that Tetra4, developer of the Virginia Gas Project in South Africa, signed its first five-year take-or-pay contract to supply contained helium to an Asian industrial gases company at an initial base price above , covering about 15% of expected Phase 1 helium capacity. Phase 1 targets start of commercial production in Q3 2026 with output of roughly 2,500 GJ/day LNG and 70 MCF/day helium. Phase 2, about 13 times larger, is expected to benefit from conditional senior debt support of up to $750 million and aims to reach around 34,000 GJ/day LNG and 900 MCF/day helium after a 44‑month build.

ASP Isotopes (NASDAQ: ASPI) restarted the first 18 stages of its Silicon-28 enrichment facility in Pretoria, South Africa, which have operated for over three weeks at target enrichment levels.

Engineering enhancements to non-core components are planned for remaining stages, supporting three U.S. contracts and expected initial commercial shipments in Q3 2026.

ASP Isotopes (NASDAQ: ASPI) announced that subsidiary Quantum Leap Energy signed a non-binding MOU with a European advanced nuclear reactor developer to assess long-term HALEU fuel supply. The framework covers uranium feedstock supply, conversion, enrichment above 10% U-235, potential deconversion, and deliveries potentially starting in 2028, with the MOU running through 2030.

Quantum Leap Energy (ASPI) appointed Dr. Peter S. Fiske to its Strategic Advisory Board on May 6, 2026. Dr. Fiske brings experience in technology commercialization, advanced materials, and government partnerships, including leadership of the DOE-backed National Alliance for Water Innovation.

The appointment follows QLE's recent SAB formation, CTO Nate Salpeter hire, and a strategic collaboration with the University of Bristol on a lithium laser research facility.